Erratum: Serotonin deficiency exacerbates acetaminophen-induced liver toxicity in mice(Scientific Reports 5(8098) 10.1038/srep08098);Serotonin deficiency exacerbates acetaminophen-induced liver toxicity in mice

Scientific Reports

Volumn 5, Issue , 2015, Pages 8098-

  Zhang, Jingyao ^a   Song, Sidong ^a   Pang, Qing ^a   Zhang, Ruiyao ^a   Zhou, Lei ^a,b   Liu, Sushun ^a   Meng, Fandi ^a   Wu, Qifei ^a   Liu, Chang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3-NITROTYROSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 2E1; CYTOKINE; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PARACETAMOL; SEROTONIN; SEROTONIN 2B RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TPH1 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE; TYROSINE;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; CELL PROLIFERATION; DEFICIENCY; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; LIVER; LIVER CELL; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; TIME FACTOR; TOXIC HEPATITIS; ULTRASTRUCTURE;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CELL PROLIFERATION; CYTOCHROME P-450 CYP2E1; CYTOKINES; DISEASE SUSCEPTIBILITY; DRUG-INDUCED LIVER INJURY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLUTATHIONE; HEPATOCYTES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; RECEPTOR, SEROTONIN, 5-HT2B; SEROTONIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRYPTOPHAN HYDROXYLASE; TYROSINE;

EID: 84923082881     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12184     Document Type: Erratum

References (61)

1. Reuben, A., Koch, D. G.&Lee, W. M. Drug-induced acute liver failure: Results of a US multicenter, prospective study. Hepatology 52, 2065-2076 (2010).
2. Larson, A.M. et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42, 1364-1372 (2005).
3. Jaeschke, H., McGill, M. R. & Ramachandran, A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44, 88-106 (2012).
4. Larson, A. M. Acetaminophen hepatotoxicity. Clin Liver Dis 11, 525-548 (2007).
5. Hinson, J., Roberts, D. & James, L. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 196, 369-405 (2010).
6. Ruepp, S. U., Tonge, R. P., Shaw, J., Wallis, N. & Pognan, F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 65, 135-150 (2002).
7. Agarwal, R. et al. Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. J Pharmacol Exp Ther 337, 110-118 (2011).
8. Bajt, M. L. et al. Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci 122, 598-605 (2011).
9. Bae, M.-A., Pie, J.-E. & Song, B. J. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH2-terminal protein kinase-related cell death pathway. Mol Pharmacol 60, 847-856 (2001).
10. Hanawa, N. et al. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283, 13565-13577 (2008).
11. Latchoumycandane, C., Goh, C. W.,Ong, M. M. & Boelsterli, U. A. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology 45, 412-421 (2007).
12. Mössner, R. & Lesch, K.-P. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12, 249-271 (1998).
13. Cloëz-Tayarani, I. & Changeux, J.-P. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 81, 599-606 (2007).
14. Lesurtel, M., Soll, C., Humar, B. & Clavien, P.-A. Serotonin: a double-edged sword for the liver? Surgeon 10, 107-113 (2012).
15. Lesurtel, M. et al. Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107 (2006).
16. Nocito, A. et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 45, 369-376 (2007).
17. Tian, Y. et al. Activation of serotonin receptor-2B rescues small-for-size liver graft failure in mice. Hepatology 53, 253-262 (2011).
18. Furrer, K. et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A 108, 2945-2950 (2011).
19. Jang, J. H. et al. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation. Hepatology 56, 209-218 (2012).
20. Nocito, A. et al. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 133, 608-618 (2007).
21. Lang, P. A. et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 14, 756-761 (2008).
22. Ruddell, R. G. et al.Arole for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169, 861-876 (2006).
23. Alpini, G. et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 68, 9184-9193 (2008).
24. Soll, C. et al. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 51, 1244-1254 (2010).
25. Izikki, M. et al. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 293, L1045-L1052 (2007).
26. Wang, F., Zhang, P., Jiang, H. & Cheng, S. Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci 57, 2856-2862 (2012).
27. Zhang, J.-Y. et al. Protective role of hydrogen-rich water on aspirin-induced gastric mucosal damage in rats. World J Gastroenterol 20, 1614-1622 (2014).
28. Qu, K. et al. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Lett 331, 105-114 (2013).
29. Alexandre, C. et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci 26, 5554-5564 (2006).
30. Das, J., Ghosh, J., Manna, P.&Sil, P. C. Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res 44, 340-355 (2010).
31. Uzi, D. et al. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol 59, 495-503 (2013).
32. Michalopoulos, G. K. & DeFrances, M. C. Liver regeneration. Science 276, 60-66 (1997).
33. Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. Hepatology 43, S45-S53 (2006).
34. Shen, H.-M. & Liu, Z.-G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 40, 928-939 (2006).
35. Sparkenbaugh, E. M. et al. The role of hypoxia-inducible factor-1a in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 338, 492-502 (2011).
36. Lammert, C., Bjornsson, E., Niklasson, A. & Chalasani, N. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51, 615-620 (2010).
37. Clavien, P. Liver regeneration: a spotlight on the novel role of platelets and serotonin. Swiss Med Wkly 138, 361 (2008).
38. Ruddell, R. G., Mann, D. A. & Ramm, G. A. The function of serotonin within the liver. J Hepatol 48, 666-675 (2008).
39. Knight, T. R., Ho, Y.-S., Farhood, A. & Jaeschke, H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther 303, 468-475 (2002).
40. Knight, T. R., Kurtz, A., Bajt, M. L., Hinson, J. A. & Jaeschke, H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 62, 212-220 (2001).
41. Bajt, M. L., Knight, T. R., Lemasters, J. J. & Jaeschke, H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by Nacetyl cysteine. Toxicol Sci 80, 343-349 (2004).
42. Murphy, M. How mitochondria produce reactive oxygen species. Biochem J 417, 1-13 (2009).
43. Jaeschke, H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284, G15-G26 (2003).
44. Ray, S. D., Mumaw, V. R., Raje, R. R. & Fariss, M. W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther 279, 1470-1483 (1996).
45. Gujral, J. S., Knight, T. R., Farhood, A., Bajt, M. L. & Jaeschke, H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67, 322-328 (2002).
46. Kon, K. et al. Role of apoptosis in acetaminophen hepatotoxicity. J Gastroenterol Hepatol 22, S49-S52 (2007).
47. Malhi, H., Gores, G. J. & Lemasters, J. J. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31-S44 (2006).
48. El-Hassan, H. et al. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases. Toxicol Appl Pharmacol 191, 118-129 (2003).
49. Boulares, A. H., Zoltoski, A. J., Stoica, B. A., Cuvillier, O. & Smulson, M. E. Acetaminophen Induces a Caspase-Dependent and Bcl-xL Sensitive Apoptosis in Human Hepatoma Cells and Lymphocytes. Pharmacol Toxicol 90, 38-50 (2002).
50. Kon, K., Kim, J. S., Jaeschke, H. & Lemasters, J. J. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 40, 1170-1179 (2004).
51. Lawson, J. A., Fisher, M. A., Simmons,C.A., Farhood,A.&Jaeschke, H. Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 156, 179-186 (1999).
52. Jaeschke, H. & Bajt, M. L. Intracellular signaling mechanisms of acetaminopheninduced liver cell death. Toxicol Sci 89, 31-41 (2006).
53. Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8, 519-529 (2007).
54. Cribb, A. E., Peyrou, M., Muruganandan, S. & Schneider, L. The endoplasmic reticulum in xenobiotic toxicity. Drug Metab Rev 37, 405-442 (2005).
55. Mehendale, H. M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 33, 41-51 (2005).
56. Apte, U. et al. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 175, 1056-1065 (2009).
57. Fontana, R. J. Acute liver failure including acetaminophen overdose. Med Clin North Am 92, 761-794 (2008).
58. Dalhoff, K. et al. Autoprotection in acetaminophen intoxication in rats: the role of liver regeneration. Pharmacol Toxicol 88, 135-141 (2001).
59. Albrecht, J. H. & Hansen, L. K. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ 10, 397-404 (1999).
60. Henderson, N. C. et al. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 56, 982-990 (2007).
61. Shen, H.-M. & Pervaiz, S. TNF receptor superfamily-induced cell death: redoxdependent execution. FASEB J 20, 1589-1598 (2006).